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Abstract: Although bacterial meningitis is a rare presentation of a congeni-
tal immunodeficiency, invasive meningococcal disease is classically associ-
ated with complement deficiencies. We report a patient from a consanguin-
eous kindred presenting with an invasive meningococcal disease caused 
by serogroup B meningococcus that revealed an underlying C5 deficiency 
caused by a novel mutation in the C5 gene.
Key Words: invasive meningococcal disease, Neisseria meningitides, com-
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Invasive meningococcal disease (IMD) is caused by Neisseria meningitidis, a common commensal member of the human upper 
respiratory tract and a major cause of bacterial meningitis and sep-
ticemia.1 Twelve serogroups of this Gram-negative have been iden-
tified, of which six (A, B, C, W-135, Y and X) are responsible for 
the majority of IMD cases worldwide.1 Serogroup B (MenB) and C 
(MenC) meningococci are responsible for the majority of the bur-
den of the disease in Europe, and the implementation of appropri-
ate meningococcal immunization programs have led to decreasing 
incidence.2 Accordingly, the incidence of IMD in Portugal has been 
declining over the past decade, in part because of the high coverage 
rate achieved after the implementation of the MenC vaccine in the 
national immunization program in 2006.2 Nevertheless, and even 
before the generalization of vaccination against MenC, MenB has 
been the most prevalent cause of IMD in Portugal, demonstrating 
the importance of high coverage rates against MenB.2
Primary immunodeficiencies (PIDs) are a heterogenous group 
of monogenic disorders that affect the development, function, or both, 
of the immune system.3 PIDs can present as recurrent, unusual or per-
sistent infection as frequent, recurrent or persistent infection, but also 
as precocious or severe autoimmunity and inflamation.3
Most infections with N. meningitidis are seen in patients 
without known predisposing factors. Presence of personal history 
of recurrent and/or invasive infections, family history of menin-
gitis or severe infections or unexplained family childhood deaths 
are suggestive of PID as an underlying cause. History of asplenia, 
treatment with eculizumab are other causes for N. meningitidis 
infections.4,5 The timely diagnosis of these conditions is crucial for 
the long-term prognosis of these patients.4
Screening for a complement deficiency is classically per-
formed on patients suffering from recurrent IMD and on those with 
an uncommon N. meningitidis serogroup.4–6
We report a patient with IMD who was screened for comple-
ment deficiency because of parental consanguinity, leading to the 
diagnosis of the first Portuguese kindred with C5 deficiency caused 
by a novel C5 gene mutation.
CASE REPORT
A 6-year-old girl was admitted to the emergency room 
because of persistent vomiting. She was discharged but returned 10 
hours later with generalized suffusions (Fig., Supplemental Digital 
Content 1, http://links.lww.com/INF/D227). Her personal medical 
history was unremarkable. Her parents were first-degree cousins, 
just like her grandparents, and there is a history of multiple deaths 
after an infection at an early age (Fig. 1).
At physical examination, the patient was oriented but hypo-
tensive (mean arterial pressure, 30 mmHg), with severe generalized 
purpura fulminans (in the trunk, legs and arms). She had no neck 
stiffness, and no papilledema was observed. Laboratory investiga-
tions are shown in Fig., Supplemental Digital Content 2, http://
links.lww.com/INF/D228.
The patient promptly received ceftriaxone (100 mg/kg/d) 
and prophylaxis with rifampicin was given to the intimate contacts. 
The patient required fluid resuscitation, then was transferred to 
pediatric intensive care unit (PICU). In PICU, she required amin-
ergic support with dopamine. With the persistence of septic shock, 
she was intubated, ventilated and received epinephrine.
N. meningitidis grew in the blood culture (later the N. men-
ingitidis was characterized by polymerase chain reaction as being 
serogroup B). Lumbar puncture was delayed until the third day of 
hospitalization because of coagulopathy. Cerebrospinal fluid was 
clear, and the cell count, proteins and glucose were within normal 
range. Polymerase chain reaction for N. meningitidis was negative 
in the cerebrospinal fluid .
She was withdrawn from mechanical ventilation after 2 days, 
the aminergic support was stopped after 5 days and she was trans-
ferred from the PICU to the Infectious Diseases Unit after 6 days. 
The patient recovered completely with minor cutaneous sequelae 
for which she received treatment by plastic surgery.
The presence of parental consanguinity prompted investiga-
tion for an underlying complement deficiency. She had absent CH100 
activity and very low C5 (Fig. 1). A 10-year-old sister also had an 
undetectable CH100 with reduced levels of C5. Sanger sequencing of 
the C5 gene revealed the presence of a novel mutation (p.Tyr352Cys) 
in homozygosity in both the patient and her sister. Bioinformatics 
analysis predicted that it affected a highly conserved residue and that 
it was pathogenic (SIFT Sorting Intolerant From Tolerant: 0.98, del-
eterious; polyphen: 0.93, probably damaging; mutation taster: disease 
causing). The parents were heterozygous for the same mutation.
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The patient and the asymptomatic sister were immunized 
with the meningococcal quadrivalent conjugate (ACWY135) vac-
cine and the 4CMenB vaccine (Bexsero, https://gsksource.com/
pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Infor-
mation/Bexsero/pdf/BEXSERO.PDF), as well as with conjugate 
and polysaccharide pneumococcal vaccines.
DISCUSSION
The complement system is an ancient proinflammatory 
and microbial destruction system that may be considered part of 
both the innate and adaptive systems.6–8 It consists of the classical, 
alternative and lectin-binding pathways. One of the goals of the 
activation of the different pathways of complement is the deposit 
of C3b on the target recognized as foreign and later activation of 
the membrane attack complex (MAC).3,7,8 The MAC is a multimo-
lecular unit composed of the terminal components of complement 
(C5–C9) that increases the immune response, resulting in opsoniza-
tion of the target particle.7,8 The MAC forms a pore that allows the 
rapid influx of ions into the bacterial cell and, thanks to the influx 
of water and swelling, rupture of the cell occurs by osmotic lysis.7,8
The MAC cannot be formed if any of components are absent. 
The role of the complement system in innate immune defenses 
against IMD is well established, and individuals deficient in com-
ponents of the terminal complement pathways are highly predis-
posed to invasive, often recurrent, meningococcal infections.8 
N. meningitidis has been the microorganism responsible for 
75%–85% of the infections identified in these patients.4,7 The infec-
tion by meningococcus has been associated with deficiency of any of 
the plasmatic proteins of complement, but the evidence has shown 
it more commonly involves deficiency of the terminal components 
of the complement pathway (40% presented at least one episode).5,9 
In fact, the association between C5 deficiency and Neisseria infec-
tion may be explained by a crucial role of C5 in bacterial killing of 
N. meningitidis recently described in a whole blood in vitro model.9
Despite the high risk for meningococcal disease, there is a 5- 
to 10-fold decrease in the probability of death because of this dis-
ease in patients with complement deficiency, when compared with 
the general population.7 It looks like the same condition that predis-
poses to infection could protect against the lethal consequences of 
the disease, because the inability to generate a functionally active 
MAC leads to reduced microbial damage and less severe endotoxin 
shock.7,9 This hypothesis is supported by Lappegård et al10, who 
have shown that C5 is essential for the Gram-negative bacteria kill-
ing and for the huge inflammatory response induced by the bacte-
ria. Ward also suggested that activated products of C5 and its bind-
ing to C5a-receptor would be responsible for loss of immune innate 
functions and development of septic shock.11 This fact suggests that 
an exacerbated response from the host is the main factor associated 
with the clinical manifestations and the outcome of the disease and 
also that the lack of C5 may protect from the most serious conse-
quences of meningococcal sepsis.1,12
It is well known that IMD can be the first and only manifes-
tation of complement deficiency, and patients are usually asympto-
matic until the first IMD takes place (many patients have the first 
episode in adulthood). Although it is difficult to decide when to 
investigate the presence of a predisposing factor, screening is classi-
cally warranted in the case of family history of IMD, recurrent IMD 
infections or when IMD is caused by an uncommon serogroup.4,7 
We propose that patients presenting IMD and with parental consan-
guinity should also be screened for complement deficiency.
In patients with IMD and known risk factors, the assessment 
of the complement function (total complement activity or CH50 or 
CH100) should be quantified.6 This is a screening assay for the activa-
tion of the classical complement pathway based on a hemolytic assay 
in which an immune complex is formed by adding antibodies that 
react with a surface antigen on sheep red blood cells.6 When sheep 
red blood cells are incubated with test serum, the classical pathway 
of complement is activated resulting in hemolysis.6 When the com-
plement function is altered, further evaluation of the components of 
the terminal pathway of complement (C5–C9) must be considered.6,7
The proper diagnosis of complement defects in a patient 
with IMD is crucial not only for prevention of recurrent infection 
in the propositus but also for the screening of asymptomatic family 
members and for genetic counselling.13 Patients with MAC defi-
ciency should be vaccinated against encapsulated bacteria, such as 
A
B
FIGURE 1. A: Family tree showing family consanguinity and the homozygous and heterozygous patients. “X”: dead family 
members. B: Concentration of complement proteins and mutation status in family members.
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N. meningitidis, Streptococcus pneumonia and Haemophilus influ-
enza type b.5,12
In summary, we report the first 2 Portuguese patients with 
C5 deficiency caused by a novel mutation in the C5 gene that 
was diagnosed after a IMD caused by MenB in a consanguineous 
family.
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Multistate Infestation With the Exotic Disease-vector  
Tick Haemaphysalis longicornis—United States, August 2017 
to September 2018
Beard CB, Occi J, Bonilla DL, et al. MMWR Morbid Mortal Wkly Rep. 
2018; 67:1310–1313
Haemaphysalis longicornis is a tick indigenous to eastern Asia and an 
important vector of human and animal disease agents, resulting in such out-
comes as human hemorrhagic fever and reduction of production in dairy 
cattle by 25%. H. longicornis was discovered on a sheep in New Jersey in 
August 2017. This was the first detection in the United States outside of 
quarantine. In the spring of 2018, the tick was again detected in the index 
site, and later, in other counties in New Jersey, in 7 other states in the eastern 
United States and in Arkansas. The hosts included 6 species of domestic 
animals, 6 species of wildlife and humans.
H. longicornis is native to eastern China, Japan, the Russian Far 
East and Korea. It is an introduced, and now established, exotic species in 
Australia, New Zealand and several island nations in the western Pacific 
Region. Where this tick exists, it is an important vector of human and ani-
mal disease agents. In China and Japan, it transmits the severe fever with 
thrombocytopenia syndrome virus, which causes a human hemorrhagic 
fever, and Rickettsia japonica, which causes Japanese spotted fever. Studies 
in Asia identified ticks infected with various species of Anaplasma, Babe-
sia, Borrelia, Ehrlichia, and Rickettsia, and all of these pathogen groups cir-
culate zoonotically in the United States. In addition, parthenogenetic repro-
duction, a biologic characteristic of this species, allows a single introduced 
female tick to generate progeny without mating, thus resulting in massive 
host infestations. In some regions of New Zealand and Australia, this tick 
can reduce production in dairy cattle by 25%.
To address this potential infectious disease threat, the U.S. Depart-
ment of Agriculture Animal and Plant Inspection Service coordinated coop-
erative enhanced surveillance efforts through telephone conference calls with 
local, state and federal agricultural and public health agencies. Through these 
efforts, enhanced vector and animal surveillance was implemented to detect 
additional tick infestations in the United States. Suspect archival specimens 
that were available among previously collected ticks were also examined.
From August 2017 to September 2018, vector and animal surveil-
lance efforts resulted in 53 reports of H. longicornis in the United States, 
including 38 (72%) from animal species [23 (61%) from domestic animals, 
13 (34%) from wildlife, and 2 (5%) from humans], and 15 (28%) from 
environmental sampling of grass or other vegetation using cloth drags or 
flags or carbon dioxide–baited tick traps. With the exception of one report 
from Arkansas, the remaining reports of positively identified ticks are from 
8 eastern states: New Jersey (16, 30%), Virginia (15, 28%), West Virginia 
(11, 21%), New York (3, 6%), North Carolina (3, 6%), Pennsylvania (2, 
4%), Connecticut (1, 2%) and Maryland (1, 2%).
Surveillance efforts did not include testing the ticks or hosts for 
pathogens. No cases of illness in humans or other species were reported. 
Concurrent reexamination of archival historical samples showed that inva-
sion occurred years earlier. Ticks collected from a deer in West Virginia in 
2010 and a dog in New Jersey in 2013 were retrospectively identified as 
H. longicornis.
Comment: The biology and ecology of H. longicornis as an exotic 
species in the United States should be characterized in terms of its vector 
competence (ability to transmit a pathogen) and vectorial capacity (feed-
ing habits, host preference, climatic sensitivity, population density and 
other factors that can affect the risk for pathogen transmission to humans) 
for tickborne pathogens known to be present in the United States. Where 
H. longicornis is detected, there should be testing for a range of indigenous 
and exotic viral, bacterial and protozoan tickborne pathogens potentially 
transmitted by H. longicornis. Given the similarity between severe fever 
with thrombocytopenia syndrome virus and Heartland virus, a tickborne 
phlebovirus, further evaluation of the potential role of H. longicornis in 
transmission of this disease agent among animal reservoirs and possibly to 
humans is warranted.
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